Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems

por Moore, Luke S P
Publicado 2020

Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design

por Rawson, Timothy M., Moore, Luke S.P.
Publicado 2023

Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19

por Hughes, Stephen, Mughal, Nabeela, Moore, Luke S. P.
Publicado 2021

Bacterial peritonitis in paediatric appendicitis; microbial epidemiology and antimicrobial management

por Bhaskar, Keir, Clarke, Simon, Moore, Luke S. P., Hughes, Stephen
Publicado 2023

Coronavirus disease 2019 (COVID-19) impact on central-line-associated bloodstream infections (CLABSI): a systematic review

por Satta, Giovanni, Rawson, Timothy M., Moore, Luke S.P.
Publicado 2023

COVID-19 and fungal superinfection

por Heard, Katie L, Hughes, Stephen, Mughal, Nabeela, Moore, Luke S P
Publicado 2020

Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study

por Hughes, Stephen, Heard, Katie L, Mughal, Nabeela, Moore, Luke S P
Publicado 2022

What are the factors driving antimicrobial resistance? Perspectives from a public event in London, England

por Castro-Sánchez, Enrique, Moore, Luke S. P., Husson, Fran, Holmes, Alison H.
Publicado 2016

Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings

por Lee, Alice E., Niruttan, Kanchana, Rawson, Timothy M., Moore, Luke S. P.
Publicado 2019

Evaluating the impact of the ICNET® clinical decision support system for antimicrobial stewardship

por Heard, Katie L., Hughes, Stephen, Mughal, Nabeela, Azadian, Berge S., Moore, Luke S. P.
Publicado 2019

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis

por Heard, Katie L, Killington, Kieran, Mughal, Nabeela, Moore, Luke S P, Hughes, Stephen
Publicado 2021

P08 Overview of general antimicrobial prescribing guidance across NHS trusts in the United Kingdom: analysis of the Induction(™) MicroGuide platform with a focus on hospital-acquir...

por Ashfield, Tom, Hughes, Stephen, Baltas, Ioannis, Amos, James, Cooray, Mineli, Moore, Luke S P
Publicado 2023

Clinical utility and cost-effectiveness of bacterial 16S rRNA and targeted PCR based diagnostic testing in a UK microbiology laboratory network

por Aggarwal, Dinesh, Kanitkar, Tanmay, Narouz, Michael, Azadian, Berge S., Moore, Luke S. P., Mughal, Nabeela
Publicado 2020

Antimicrobial use, drug-resistant infections and COVID-19

por Rawson, Timothy M., Ming, Damien, Ahmad, Raheelah, Moore, Luke S. P., Holmes, Alison H.
Publicado 2020

Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review

por Soriano, Alex, Carmeli, Yehuda, Omrani, Ali S., Moore, Luke S. P., Tawadrous, Margaret, Irani, Paurus
Publicado 2021

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants

por Pallett, Scott J C, Heskin, Joseph, Groppelli, Elisabetta, Mazzella, Andrea, Moore, Luke S P
Publicado 2022

Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations

por Rawson, Timothy M, Antcliffe, David B, Wilson, Richard C, Abdolrasouli, Alireza, Moore, Luke S P
Publicado 2023

Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence

por Skolimowska, Keira, Rayment, Michael, Jones, Rachael, Madona, Pinglawathee, Moore, Luke S.P., Randell, Paul
Publicado 2020

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection

por Pallett, Scott J C, Jones, Rachael, Randell, Paul, Davies, Gary W, Moore, Luke S P
Publicado 2021

Novel inhaled antifungal for pseudomembranous Aspergillus tracheobronchitis complicating connective tissue disease

por Singh, Shivani, Moore, Luke S P, Mughal, Nabeela, Ho, Matthew, Armstrong-James, Darius, Singh, Suveer
Publicado 2023